Galantamine vs Donepezil in the Treatment of Alzheimer's Disease

Author： Goldlist B.   Gordon M.   Naglie G.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.20, Iss.15, 2003-01, pp. : 1139-1140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease

By Wilcock G.  

Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. : 777-789

Adis International

Access to resources Recommend Favorite

The pharmacology of donepezil: a new treatment for Alzheimer’s disease

By Wilkinson D.G.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 121-135

Informa Healthcare

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Donepezil vs rivastigmine in Alzheimer's disease - same benefits, different downsides

By  

Inpharma, Vol. 1, Iss. 1300, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Current status and new developments with galantamine in the treatment of Alzheimer’s disease

By Tariot Pierre  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 2027-2049

Informa Healthcare

Access to resources Recommend Favorite